The natalizumab wearing-off effect End of natalizumab cycle, recurrence of MS symptoms

van Kempen, ZLE; Doesburg, D; Dekker, I; Lissenberg-Witte, BI; de Vries, A; Claessen, IA; ten Brinke, A; Rispens, T; Killestein, J

van Kempen, ZLE (reprint author), Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.; van Kempen, ZLE (reprint author), MS Ctr Amsterdam, Amsterdam Neurosci, Dept Neurol, Amsterdam, Netherlands.

NEUROLOGY, 2019; 93 (17): E1579

Abstract

Objective Natalizumab is effective in treating relapsing-remitting multiple sclerosis (RRMS). However, many patients report an increase of multiple sc......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索